Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study – CNBC By Weight Loss Haven Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study CNBC Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest